MiR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells

International Journal of Oncology

Volumn 42, Issue 4, 2013, Pages 1443-1451

  Dynoodt, Peter ^a   Speeckaert, Reinhart ^a   De Wever, Olivier ^a   Chevolet, Inès ^a   Brochez, Lieve ^a   Lambert, Jo ^a   Van Gele, Mireille ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Fascin homolog 1; Melanoma; MiR 145; Suppressor of invasion

Indexed keywords

BLOOM SYNDROME HELICASE; FASCIN HOMOLOG 1 PROTEIN; FM3P PROTEIN; MICRORNA 145; MYOSIN VA; RAB27A PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; WM793 PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GAIN OF FUNCTION MUTATION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; METASTASIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MELANOCYTES; MELANOMA; MICROFILAMENT PROTEINS; MICRORNAS; NEOPLASM INVASIVENESS; RNA INTERFERENCE; SKIN NEOPLASMS;

EID: 84874639663     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1823     Document Type: Article

References (31)

1. Garbe C and Leiter U: Melanoma epidemiology and trends. Clin Dermatol 27:3-9, 2009.
2. Chin L: The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer 3:559-570, 2003.
3. Lin K, Baritaki S, Militello L, Malaponte G, Bevelacqua Y and Bonavida B: The role of B-RAF mutations in melanoma and the induction of EMT via dysregulation of the NF-κB/Snail/RKIP/PTEN circuit. Genes Cancer 1:409-420, 2010.
4. Howell PM Jr, Li X, Riker AI and Xi Y: MicroRNA in melanoma. Ochsner J 10:83-92, 2010.
5. Mueller DW and Bosserhoff AK: Role of miRNAs in the progression of malignant melanoma. Br J Cancer 101:551-556, 2009.
6. Mueller DW and Bosserhoff AK: The evolving concept of 'melano-miRs'-microRNAs in melanomagenesis. Pigment Cell Melanoma Res 23:620-626, 2010.
7. Molnár V, Tamási V, Bakos B, Wiener Z and Falus A: Changes in miRNA expression in solid tumors: an miRNA profling in melanomas. Semin Cancer Biol 18:111-122, 2008.
8. Segura MF, Belitskaya-Lévy I, Rose AE, et al: Melanoma microRNA signature predicts post-recurrence survival. Clin Cancer Res 16:1577-1586, 2010.
9. Sachdeva M and Mo YY: miR-145-mediated suppression of cell growth, invasion and metastasis. Am J Transl Res 2:170-180, 2010.
10. Iorio M V, Ferracin M, Liu CG, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065-7070, 2005.
11. Noguchi S, Mori T, Hoshino Y, et al: Comparative study of anti-oncogenic microRNA-145 in canine and human malignant melanoma. J Vet Med Sci 74:1-8, 2012.
12. Kirkin AF, Petersen TR, Olsen AC, Li L, Thor Straten P and Zeuthen J: Generation of human-melanoma-specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines. Cancer Immunol Immunother 41:71-81, 1995.
13. Naeyaert JM, Eller M, Gordon PR, Park HY and Gilchrest BA: Pigment content of cultured human melanocytes does not correlate with tyrosinase message level. Br J Dermatol 125:297-303, 1991.
14. Van Gele M, Geusens B, Schmitt AM, Aguilar L and Lambert J: Knockdown of myosin Va isoforms by RNAi as a tool to block melanosome transport in primary human melanocytes. J Invest Dermatol 128:2474-2484, 2008.
15. Vandesompele J, De Paepe A and Speleman F: Elimination of primer-dimer artifacts and genomic coamplification using a two-step SYBR green I real-time RT-PCR. Anal Biochem 303:95-98, 2002.
16. Vandesompele J, De Preter K, Pattyn F, et al: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: Research0034, 2002.
17. De Wever O, Hendrix A, De Boeck A, et al: Modeling and quantification of cancer cell invasion through collagen type I matrices. Int J Dev Biol 54:887-896, 2010.
18. Dynoodt P, Mestdagh P, Van Peer G, et al: Identification of miR-145 as a key regulator of the pigmentary process. J Invest Dermatol: August 16, 2012 (E-pub ahead of print). doi:10.1038/jid.2012.266.
19. Chiyomaru T, Enokida H, Tatarano S, et al: miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 102:883-891, 2010.
20. Fuse M, Nohata N, Kojima S, et al: Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1. Int J Oncol 38:1093-1101, 2011.
21. Kim SJ, Oh JS, Shin JY, et al: Development of microRNA-145 for therapeutic application in breast cancer. J Control Release 155:427-434, 2011.
22. Mascellani N, Tagliavini L, Gamberoni G, et al: Using miRNA expression data for the study of human cancer. Minerva Biotec 20:23-30, 2008.
23. Sachdeva M, Zhu S, Wu F, et al: p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 106:3207-3212, 2009.
24. Sachdeva M and Mo YY: MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res 70:378-387, 2010.
25. Yang B, Guo H, Zhang Y, Chen L, Ying D and Dong S: MicroRNA-145 regulates chondrogenic differentiation of mesenchymal stem cells by targeting Sox9. PLoS One 6:e21679, 2011.
26. Kureishy N, Sapountzi V, Prag S, Anilkumar N and Adams JC: Fascins, and their roles in cell structure and function. Bioessays 24:350-361, 2002.
27. Hashimoto Y, Skacel M and Adams JC: Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int J Biochem Cell Biol 37:1787-1804, 2005.
28. Yildiz L, Kefeli M, Aydin O and Kandemir B: Fascin expression in melanocytic lesions of the skin. Eur J Dermatol 19:445-450, 2009.
29. Goncharuk VN, Ross JS and Carlson JA: Actin-binding protein fascin expression in skin neoplasia. J Cutan Pathol 29:430-438, 2002.
30. Zhang J, Guo H, Zhang H, et al: Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene. Cancer 117:86-95, 2011.
31. Götte M, Mohr C, Koo CY, et al: miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness. Oncogene 29:6569-6580, 2010.